Canton Strategic Holdings (CNTN) Assets (2020 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Assets came in at $584.7 million in Q1 2026, up 35092.72% YoY from N/an in Q1 2025, and up 12.62% on a QoQ basis from $519.1 million in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Assets (2020 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 7 years of Assets data on file, last reported at $584.7 million in Q1 2026.
- Quarterly Assets rose 35092.72% year-over-year to $584.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $584.7 million (up 35092.72% YoY) and the FY2025 annual result came in at $519.1 million, up 13849.46% from the prior year.
- Assets climbed to $584.7 million in Q1 2026, from $519.1 million in the prior quarter.
- In the past five years, Assets ranged from a high of $584.7 million in Q1 2026 to a low of $1.7 million in Q1 2025.
- A 5-year average of $70.7 million and a median of $7.7 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2025 — Assets plunged 81.31% — and 2026, when it soared 35092.72%.
- Tracing CNTN's Assets over 5 years: stood at $6.7 million in 2022, then surged by 63.66% to $10.9 million in 2023, then plunged by 66.0% to $3.7 million in 2024, then jumped by 13849.46% to $519.1 million in 2025, then advanced by 12.62% to $584.7 million in 2026.
- The last three Assets figures came in at $584.7 million (Q1 2026), $519.1 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 10.96 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.32 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9.18 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | 564.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 564.57 Mn |
| Mar 31, 2026 | 584.65 Mn |
| Dec 31, 2025 | 519.15 Mn |
| Sep 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | 8.26 Mn |
| Mar 31, 2024 | 8.89 Mn |
| Dec 31, 2023 | 10.95 Mn |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 4.72 Mn |
| Dec 31, 2022 | 6.69 Mn |
| Sep 30, 2022 | 8.02 Mn |
| Jun 30, 2022 | 10.25 Mn |
| Mar 31, 2022 | 12.09 Mn |
| Dec 31, 2021 | 621,677.00 |
| Dec 31, 2020 | 294,798.00 |